Published in:
01-05-2017 | Editorial
Statins in patients with sepsis and ARDS: is it over? We are not sure
Authors:
Danny McAuley, Pierre-Emmanuel Charles, Laurent Papazian
Published in:
Intensive Care Medicine
|
Issue 5/2017
Login to get access
Excerpt
Statins are lipid-lowering agents which act by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase and are generally used for cardiovascular prevention. Statins, however, also present anti-inflammatory and immunomodulating effects which could be of interest in sepsis and acute respiratory distress syndrome (ARDS). Many experimental investigations and some epidemiological studies support this theoretical beneficial effect. However, recent interventional studies which showed no benefit have been discouraging and do not support the use of statins in septic and/or ARDS patients. …